UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000015123
Receipt number R000017592
Scientific Title Phase II trial of S-1 plus Cetuximab combination therapy in patients inappropriate for platinum-based therapy with recurrent/metastatic squamous cell carcinoma of the head and neck
Date of disclosure of the study information 2014/09/11
Last modified on 2019/10/06 00:53:04

No. Disposal Last modified on Item of update
1 Insert 2014/09/11 16:51:12
2 Update 2015/04/14 20:48:09 Recruitment status
3 Update 2015/09/11 19:20:18 Key inclusion criteria
Key inclusion criteria
4 Update 2017/03/28 09:02:01 Name of primary person or sponsor
Organization
5 Update 2018/04/19 20:24:08 Key inclusion criteria
Key inclusion criteria
6 Update 2019/05/01 14:50:24 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Organization
Organization
Division name
Zip code

Last name of contact person

Last name of contact person
Organization
Organization
Division name
Zip code
Organization
Organization
Division name
Tel1
Organization
Organization
Address
Address
Tel
Email
7 Update 2019/05/01 15:13:16 Recruitment status
Date of IRB
Last follow-up date
8 Update 2019/05/01 15:16:42 Number of participants that the trial has enrolled
9 Update 2019/10/06 00:53:04 Recruitment status